[go: up one dir, main page]

Kowey et al., 1982 - Google Patents

Effects of prostacyclin (PGI2) on vulnerability to ventricular fibrillation in the normal and ischemic canine heart

Kowey et al., 1982

Document ID
5355958341024605278
Author
Kowey P
Verrier R
Lown B
Publication year
Publication venue
European Journal of Pharmacology

External Links

Snippet

Prostacyclin (PGI 2) has been shown to have a number of beneficial effects on the cardiovascular system. However, its effects on ventricular electrical properties remain unexplored. We studied the effects of this naturally occuring humoral agent on ventricular …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation, e.g. heart pace-makers
    • A61N1/362—Heart stimulators
    • A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
    • A61N1/36514—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/056—Transvascular endocardial electrode systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/04—Detecting, measuring or recording bioelectric signals of the body of parts thereof
    • A61B5/0402—Electrocardiography, i.e. ECG
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR

Similar Documents

Publication Publication Date Title
Axelrod et al. Vulnerability to ventricular fibrillation during acute coronary arterial occlusion and release
BROOKS et al. Protective effect of verapamil on vulnerability to ventricular fibrillation during myocardial ischaemia and reperfusion
Burack et al. Transesophageal cardiac pacing
Inoue et al. Conduction over an isthmus of atrial myocardium in vivo: a possible model of Wolff-Parkinson-White syndrome.
US20110040248A1 (en) Methods and implantable devices for treating supraventricular arrhythmias
Sheehan et al. Effects of calcium channel blocking agents on reperfusion arrhythmias
Hashimoto et al. The isolated and cross-circulated AV node preparation of the dog
Pickar et al. Stimulation of vagal afferents inhibits locomotion in mesencephalic cats
Taggart et al. d-Sotalol: a new potent class III anti-arrhythmic agent
Stockman et al. Effect of nitroglycerin on vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion
US4604394A (en) Antiarrhythmic compositions and method
Russell et al. Cardiovascular response to Crotalus venom
RUDE et al. Effects of amrinone on experimental acute myocardial ischaemic injury
Randall et al. Acute cardiovascular consequences of anterior descending coronary artery occlusion in unanesthetized monkey
Kowey et al. Influence of intracoronary platelet aggregation on ventricular electrical properties during partial coronary artery stenosis
Kowey et al. Effects of prostacyclin (PGI2) on vulnerability to ventricular fibrillation in the normal and ischemic canine heart
Ulano et al. Selective dilation of the constricted superior mesenteric artery
Malfatto et al. The response to overdrive pacing of triggered atrial and ventricular arrhythmias in the canine heart.
Kopia et al. Antiarrhythmic and electrophysiologic actions of clofilium in experimental canine models
Hachenbero et al. Cardiopulmonary effects of internal cardioverter/defibrillator implantation
Birnbaum et al. Mechanisms in the production of atrial fibrillation during asphyxia
Garson Ventricular dysrhythmias after congenital heart surgery: a canine model
Stanton et al. Modulation of drug effects by regional sympathetic denervation and supersensitivity.
MOÏSE et al. Phenylephrine‐Induced Ventricular Arrhythmias in Dogs with Inherited Sudden Death
Donaldson et al. Differential effects of ischaemia and hyperkalaemia on myocardial repolarization and conduction times in the dog.